Mr. Forschbach’s representative matters over the last two years include advising:

• Astorg and Goldman Sachs in the sale of HRA Pharma, a rapidly expanding innovation-driven consumer healthcare company, to Perrigo
• Astorg in its acquisition of Solina, the leading European manufacturer of ingredient and seasoning blends for the food industry from Ardian
• Elsan Group, a portfolio company of KKR, in its acquisition of  Groupe C2S, a France-based company operating private clinics
• KKR and the founders of Webhelp in the €2.4 billion sale of the company to GBL (International)
• Astorg in the sale and reinvestment in Audiotonix, premier audio mixing consoles provider
• Astorg in its acquisition of eResearchTechnology, Inc. (ERT), a leading global data and technology company
• Eurazeo Capital in its acquisition of Dutch Ophthalmic Research Center (DORC), a medical technology company from Montagu
• Astorg Partners in the acquisition of Anaqua Inc., an IP administration business from Insight Venture Partners
• BC Partners in its sale of the Antelliq Group, a France-based developer of digital animal identification, traceability, and monitoring solutions to Merck for €3.25 billion
• Intermediate Capital Group in its sale of the Stella Group, a France-based manufacturer of custom-made curtains, roller shutters, gates, and sectional doors, to PAI Partners
• Astorg in its acquisition of Nemera, a leading global manufacturer of drug administration systems for the pharmaceutical industry from Montagu
• Ardian in its sale of Groupe SIACI SAINT HONORE to Charterhouse
• Caisse de Depot et Placement du Quebec (CDPQ) in its acquisition of a minority, and stake in Sebia, a France-based company that researches, develops, and manufactures analytical and diagnostic systems